Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this exciting session on understanding seronegative rheumatoid arthritis.
Rheumatoid arthritis (RA) is an autoimmune disease that causes joint pain, inflammation, and damage throughout your body. It is often difficult to diagnose in the early stages as it mimics other diseases.
Seronegative rheumatoid arthritis is one such type that is highly difficult to diagnose. Some of the most important symptoms in diagnosing seronegative rheumatoid arthritis include- joint pain, stiffness specifically in the hands but also in knees, elbows, hips, feet and ankles, and so on. Specific biomarkers are also there to diagnose the same.
Therefore, listen to the webinar, grab the shared knowledge, and follow HiDoc for more such exciting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.
2.
Study identifies new approach to protect the brain during radiation therapy
3.
While most cancer screenings won't prolong lives, there are still good reasons to continue screening.
4.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
5.
Radiation therapy for patients with breast cancer
1.
Radiation in Oncology: Advances, Applications, and Accessibility
2.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
3.
Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy
4.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
5.
Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Navigating the Complexities of Ph Negative ALL - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation